KEAP1 and metabolic dysfunction-associated steatohepatitis: In previous studies conducted in Nrf2‐knockout mice and Keap1‐knockdown mice in which NRF2 was constitutively activated, we reported that NRF2 had protective roles against NASH through the inhibition of oxidative stress and fibrosis in the liver.18